Biodeal Pharmaceuticals - About the company
Biodeal Pharmaceuticals is a series B company based in Delhi (India), founded in 2007. It operates as a Manufacturer of pharmaceutical formulations. Biodeal Pharmaceuticals has raised $13.2M in funding. The company has 878 active competitors, including 27 funded and 139 that have exited. Its top competitors include companies like Akums, Rubicon and Jubilant Life Sciences.
Company Details
- Website
- biodealpharma.com
- Email ID
- *****@biodealpharma.com
- Phone Number
- +91 **********
- Registered Address
- VILLAGE SAINI MAJRA,NALAGARH-ROPAR ROAD, TEH. NALAGARH, DISTT. SOLAN (HP)., NALAGARH, DISTT. SOLAN (HP)., Himachal Pradesh, India, 000000
Key Metrics
Founded Year
2007
Location
Delhi, India
Stage
Series B
Total Funding
$13.2M in 1 round
Latest Funding Round
Investors
Ranked
60th among 878 active competitors
Annual Revenue
₹209Cr as on Mar 31, 2025
Employee Count
756 as on Feb 28, 2025
Legal entities associated with Biodeal Pharmaceuticals
Biodeal Pharmaceuticals is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Biodeal Pharmaceuticals Limited CIN: U00304HP2005PLC029451 , India, Active | Dec 30, 2005 | $24.8M (As on Mar 31, 2025) | 422 (As on Aug 01, 2025) |
Sign up to download Biodeal Pharmaceuticals' company profile
Biodeal Pharmaceuticals's funding and investors
Biodeal Pharmaceuticals has raised a total funding of $13.2M over 1 round. Its latest funding round was a Series B round on Apr 08, 2024 for $*****. 1 investor participated in its latest round. Biodeal Pharmaceuticals has 1 institutional investor.
Here is the list of recent funding rounds of Biodeal Pharmaceuticals:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Apr 08, 2024 | 5887282 | Series B | 1198332 | 5747504 | 1871138 | 4865719 |
Access funding benchmarks and valuations. Sign up today!View details of Biodeal Pharmaceuticals's funding rounds and investors
Biodeal Pharmaceuticals' founders and board of directors
Founder? Claim ProfileBiodeal Pharmaceuticals' employee count trend
Biodeal Pharmaceuticals has 756 employees as of Feb 25. Here is Biodeal Pharmaceuticals's employee count trend over the years:
Uncover Biodeal Pharmaceuticals' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Biodeal Pharmaceuticals's Competitors and alternates
Top competitors of Biodeal Pharmaceuticals include Akums, Rubicon and Jubilant Life Sciences. Here is the list of Top 10 competitors of Biodeal Pharmaceuticals, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | CDMO focusing on spectrum of dosage forms and therapeutic segments | $70M | 60/100 | ||
2nd | CDMO offering drug development services through its proprietary drug delivery technologies | $4.62M | 60/100 | ||
3rd | Jubilant Life Sciences 1978, Noida (India), Public | Company offering a suite of R&D and manufacturing services for small molecules and generics | - | 59/100 | |
4th | Contract services for pharmaceutical development and manufacturing | - | 57/100 | ||
5th |  Nivagen Pharmaceuticals 2009, Sacramento (United States), Acquired | Developer and contract manufacturer of generic drugs, tablets, capsules, ointment and solution | $31M | 56/100 | |
6th |  Nectar Lifesciences 1995, Chandigarh (India), Public | Manufacturer of cephalosporin APIs and generic formulations | $46.9M | 56/100 | |
7th |  Ipca Laboratories 1949, Mumbai (India), Public | Manufacturer of pharmaceutical formulations, active pharmaceutical ingredients, and generic medications | - | 56/100 | |
8th | SAVA group 2003, Pune (India), Unfunded | Pharma company with a portfolio of domestic and export products, also offering CRAMS services | - | - | 56/100 |
9th | _1573725531895.png?devicePixelRatio=2&height=30&width=30){kind=logo} Supriya Lifescience 2008, Mumbai (India), Public | Manufacturer of active pharmaceutical ingredients and finished dosage formulations for healthcare | - | - | 54/100 |
10th | Halo Pharma 2006, Hanover (United States), Acquired | CDMO offering integrated drug development services | $25M | 53/100 | |
60th | Biodeal Pharmaceuticals 2007, Delhi (India), Series B | Manufacturer of pharmaceutical formulations | $13.2M | 41/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Biodeal Pharmaceuticals's competitors? Click here to see the top ones
Biodeal Pharmaceuticals's Investments and acquisitions
Biodeal Pharmaceuticals has made no investments or acquisitions yet.
News related to Biodeal Pharmaceuticals
•
Piramal Alternatives invests ₹110 crore in Biodeal PharmaThe Hindu•Apr 08, 2024•Piramal Group, Biodeal Pharmaceuticals
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Biodeal Pharmaceuticals
Explore our recently published companies
- Kaizen - Unfunded company
- Ford Country - Henderson based, 1996 founded, Unfunded company
- A2Z Creations - Panipat based, 2015 founded, Unfunded company
- IRG Commercial - Altamonte Springs based, 1989 founded, Unfunded company
- GMR Quality Stone Products - Sterling Heights based, 2002 founded, Unfunded company
- Socalweb - Los Angeles based, 2004 founded, Unfunded company
